Bausch Health Companies Inc. (BHC)

NYSE • Currently up 0.13 (+2.78%) in today's trading session

1 member of Congress has disclosed 3 trades in Bausch Health Companies Inc. (BHC) via STOCK Act filings. The most recent disclosure was a sale by Susie Lee on 27 August 2020. Aggregate disclosed activity totals roughly $16K in purchases and $8K in sales (midpoint estimates from bracketed disclosure amounts).

Bausch Health Companies Inc. is currently trading at $4.80, positioned at 6% of its 52-week range ($4.57 – $8.69).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Copy PortfolioClaim Free Asset
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$4.80
24h Change
+0.13 (+2.78%)
52 Week Range
$4.57—$8.69
View on NASDAQ

Bausch Health Companies Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for BHC

Select to highlight on chart
3 transactions
Compliance: 100%
Susie Lee27 Aug 20207 Oct 2020SaleStock$1,001 - $15,000N/A
Susie Lee24 Feb 202028 Apr 2020PurchaseStock$1,001 - $15,000N/A
Susie Lee6 Jan 202025 Feb 2020PurchaseStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$1.79B

Volume

1.19M

Beta

0.41

P/E Ratio

-1.48

Fundamentals

EPS

$-3.24

Div. Yield

—

Open

$4.69

Day Range

$4.69 — $4.80

Company Information

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NYSE · USD
Country
CA
CEO
Thomas J. Appio
IPO Date
1994-03-29
Website
www.bauschhealth.com

Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary th...

Earnings

Next Report

Q2 2026

29 Jul

EPS Est.

$0.96

Rev. Est.

$2.6B

Days Until

36

Recent Quarters

Q1 202629 Apr
EPS$0.78
Miss 3.7%
Q4 202518 Feb
EPS$1.08
Miss 10.7%
Q3 202529 Oct
EPS$1.16
Beat 8.4%
Q2 202530 Jul
EPS$0.90
Miss 7.2%
Q1 202530 Apr
EPS$0.59
Miss 28.9%
Q4 202419 Feb
EPS$1.15
Miss 30.3%
Q3 202430 Oct
EPS$1.12
Beat 8.7%
Q2 20241 Aug
EPS$0.89
Beat 1.1%
Q1 20242 May
EPS$0.59
Miss 21.3%
Q4 202322 Feb
EPS$1.15
Beat 13.9%
Q3 20232 Nov
EPS$1.03
Beat 12.0%
Q2 20233 Aug
EPS$0.81
Beat 8.0%
Q1 20234 May
EPS$0.52
Miss 30.7%
Q4 202223 Feb
EPS$1.02
Beat 10.9%
Q3 20223 Nov
EPS$0.76
Miss 17.4%
Q2 20229 Aug
EPS$0.55
Miss 38.2%
Q1 202210 May
EPS$0.72
Miss 30.1%
Q4 202123 Feb
EPS$1.27
Beat 17.6%
Q3 20212 Nov
EPS$1.14
Beat 6.5%
Q2 20213 Aug
EPS$0.98
Beat 1.0%
Q1 20214 May
EPS$1.04
Beat 10.6%
Q4 202024 Feb
EPS$1.33
Beat 19.8%
Q3 20203 Nov
EPS$1.31
Beat 28.4%
Q2 20206 Aug
EPS$0.47
Miss 28.8%
Q1 20207 May
EPS$0.89
Miss 1.1%
Q4 201919 Feb
EPS$1.15
Beat 0.0%
Q3 20194 Nov
EPS$1.19
Beat 12.3%
Q2 20196 Aug
EPS$1.03
Miss 2.8%
Q1 20196 May
EPS$1.03
Beat 15.7%
Q4 201820 Feb
EPS$1.05
Beat 19.3%
Q3 20186 Nov
EPS$1.15
Beat 32.2%
Q2 20187 Aug
EPS$0.93
Beat 14.8%
Q1 20188 May
EPS$0.88
Beat 46.7%
Q4 201728 Feb
EPS$0.98
Beat 1.0%
Q3 20177 Nov
EPS$1.04
Beat 16.9%
Q2 20178 Aug
EPS$1.03
Beat 9.6%
Q1 20179 May
EPS$0.78
Miss 10.3%
Q4 201628 Feb
EPS$1.26
Beat 5.0%
Q3 20168 Nov
EPS$1.55
Miss 11.4%
Q2 20169 Aug
EPS$1.40
Miss 4.8%
Q1 20167 Jun
EPS$1.27
Miss 7.3%
Q4 201515 Mar
EPS$2.50
Miss 4.2%
Q3 201519 Oct
EPS$2.74
Beat 1.5%
Q2 201523 Jul
EPS$2.56
Beat 4.1%
Q1 201529 Apr
EPS$2.36
Beat 0.8%
Q4 201423 Feb
EPS$2.58
Beat 1.2%
Q3 201420 Oct
EPS$2.11
Beat 6.0%
Q2 201431 Jul
EPS$1.91
Beat 0.5%
Q1 20148 May
EPS$1.76
Beat 2.3%
Q4 201327 Feb
EPS$2.15
Beat 4.4%
Q3 201331 Oct
EPS$1.43
Beat 1.4%
Q2 20137 Aug
EPS$1.34
Beat 4.7%
Q1 20132 May
EPS$1.30
Beat 4.0%
Q4 201228 Feb
EPS$1.22
Beat 1.7%
Q3 20122 Nov
EPS$1.15
Beat 2.7%
Q2 20122 Aug
EPS$1.01
Beat 2.0%
Q1 20123 May
EPS$0.99
Beat 3.1%
Q4 201127 Feb
EPS$0.94
Beat 10.6%
Q3 20113 Nov
EPS$0.66
Beat 15.8%
Q2 20114 Aug
EPS$0.73
Beat 10.6%
Q1 20119 May
EPS$0.62
Beat 21.6%
Q4 201024 Feb
EPS$0.51
Beat 13.3%
Q3 20104 Nov
EPS$0.44
Miss 8.3%
Q2 20105 Aug
EPS$0.60
Beat 130.8%
Q1 20106 May
EPS$0.59
Beat 118.5%
Q4 200925 Feb
EPS$0.56
Beat 51.4%
Q3 20095 Nov
EPS$0.32
Miss 20.0%
Q2 20096 Aug
EPS$0.34
Beat 0.0%
Q1 20096 May
EPS$0.28
Miss 6.7%
Q4 200826 Feb
EPS$0.34
Beat 6.3%
Q3 20086 Nov
EPS$0.36
Beat 24.1%
Q2 200813 Aug
EPS$0.37
Beat 8.8%
Q1 20088 May
EPS$0.38
Miss 2.6%
Q4 200713 Mar
EPS$0.45
Beat 15.4%
Q3 20078 Nov
EPS$0.42
Beat 5.0%
Q2 20078 Aug
EPS$0.40
Beat 8.1%
Q1 200710 May
EPS$0.58
Beat 52.6%
Q4 200615 Mar
EPS$0.93
Beat 20.8%
Q3 20069 Nov
EPS$0.83
Beat 27.7%
Q2 200610 Aug
EPS$0.50
Beat 8.7%
Q1 200611 May
EPS$0.43
Beat 16.2%
Q4 200523 Mar
EPS$0.77
Beat 4.0%
Q3 200511 Nov
EPS$0.69
Beat 15.0%
Q2 20054 Aug
EPS$0.34
Beat 30.8%
Q1 20055 May
EPS$0.07
Beat 0.0%
Q4 200410 Mar
EPS$0.58
Beat 16.0%
Q3 20044 Nov
EPS$0.31
Miss 16.2%
Q2 20044 Aug
EPS$0.28
Beat 16.7%
Q1 200429 Apr
EPS$0.18
Beat 38.5%
Q4 20033 Mar
EPS$0.28
Beat 0.0%
Q3 200330 Oct
EPS$0.22
Miss 43.6%
Q2 200329 Jul
EPS$0.52
Beat 10.6%
Q1 200329 Apr
EPS$0.39
Beat 2.6%
Q4 20024 Mar
EPS$0.60
Beat 5.3%
Q3 200229 Oct
EPS$0.47
Beat 2.2%
Q2 200225 Jul
EPS$0.39
Beat 2.6%
Q1 200225 Apr
EPS$0.32
Beat 6.7%
Q4 200121 Feb
EPS$0.46
Beat 7.0%
Q3 200129 Oct
EPS$0.37
Beat 2.8%
Q2 20011 Aug
EPS$0.30
Beat 20.0%
Q1 200126 Apr
EPS$0.20
Beat 11.1%
Q4 200028 Feb
EPS$0.28
Beat 7.7%
Q3 200027 Oct
EPS$0.27
Beat 8.0%
Q2 20002 Aug
EPS$0.17
Beat 6.3%
Q1 200028 Apr
EPS$0.10
Beat 0.0%
Q4 199924 Feb
EPS$0.20
Beat 5.3%
Q3 199928 Oct
EPS$0.18
Beat 5.9%
Q2 199928 Jul
EPS$0.12
Beat 0.0%
Q1 199929 Apr
EPS$0.09
Beat 0.0%
Q4 199826 Feb
EPS$0.14
Beat 7.7%
Q3 199827 Nov
EPS$0.12
Beat 0.0%
Q2 199828 Jul
EPS$0.09
Beat 0.0%
Q1 199829 Apr
EPS$0.07
Beat 0.0%
Q4 199725 Feb
EPS$0.13
Beat 62.5%
Q2 199730 Sept
EPS$0.10
Q2 199724 Jul
EPS$0.07
Beat 0.0%
Q1 199728 Apr
EPS$0.06
Beat 0.0%
Q4 199627 Feb
EPS$0.07
Beat 16.7%
Q3 199629 Oct
EPS$0.06
Beat 0.0%
Q2 199617 Jul
EPS$0.06
Beat 32.7%
Q1 199617 Apr
EPS$0.05
Beat 71.4%
Q3 199531 Dec
EPS$0.03
Q2 199530 Sept
EPS$0.01
Q1 199530 Jun
EPS$0.00
Q4 199431 Mar
EPS$0.01
Q3 199431 Dec
EPS$0.00
Q2 199430 Sept
EPS$0.01
Q1 199430 Jun
EPS$-0.05
Q4 199331 Mar
EPS$0.05

Dividends

Dividend History

10 Nov 2010
Amount $1.0000
30 Aug 2010
Amount $0.0950
28 May 2010
Amount $0.0950
4 Mar 2010
Amount $0.0900
30 Nov 2009
Amount $0.0900
28 Aug 2009
Amount $0.0900
13 May 2009
Amount $0.0900
6 Mar 2009
Amount $0.3750
19 Dec 2008
Amount $0.3750
21 Aug 2008
Amount $0.3750
20 May 2008
Amount $0.3750
25 Mar 2008
Amount $0.3750
16 Nov 2007
Amount $0.3750
16 Aug 2007
Amount $0.3750
18 May 2007
Amount $0.3750
22 Mar 2007
Amount $0.3750
8 Jan 2007
Amount $0.5000
20 Nov 2006
Amount $0.1250
16 Aug 2006
Amount $0.1250
19 May 2006
Amount $0.1250
5 Apr 2006
Amount $0.1250
28 Nov 2005
Amount $0.5000

Stock Splits

Split History

16 Oct 2000Stock Split
Ratio2:1
20 Jan 2000Stock Split
Ratio1:1
10 Jan 2000Stock Split
Ratio2:1
17 Jan 1996Stock Split
Ratio1:1

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

IVV

iShares Core S&P 500 ETF

20
$737.14-10.64 (-1.42%)
Financial Services
Held by same politician
Significant holdings value
1 politician
View Stock

VRT

Vertiv Holdings Co

20
$318.32-39.64 (-11.07%)
Industrials
Held by same politician
Significant holdings value
1 politician
View Stock

SUB

iShares Short-Term National Muni Bond ETF

17
$106.42-0.14 (-0.13%)
Financial Services
Held by same politician
1 politician
View Stock

Frequently Asked Questions about BHC

Which members of Congress have traded BHC?
1 member of Congress has disclosed 3 trade in Bausch Health Companies Inc. (BHC) under the STOCK Act: Susie Lee.
When was BHC most recently disclosed by Congress?
The most recent BHC disclosure was a sale by Susie Lee on 27 August 2020.
What is the total disclosed congressional trading volume for BHC?
Members of Congress have disclosed approximately $16K in BHC purchases and $8K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in BHC?
This BHC page updates as soon as new STOCK Act disclosures are filed for Bausch Health Companies Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
Follow on XJoin our Discord
PoliticiansBillsPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.